Buscar
13 estudios coinciden con estos filtros. Mostrando 1–13 de 13 estudios
| Número de registro | Estudio | Estado | Fase | Inscripción | Centros / países | Año de inicio | Última actualización | Acciones |
|---|---|---|---|---|---|---|---|---|
| NCT06915233 | A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle The objective of this study is to demonstrate the superiority of MACI (autologous cultured chondrocytes on porcine collagen membrane) versus Bone Marrow Stimulation in the treatment of patients aged 17 to 65 years with symptomatic articular chondral or osteochondral defects of the talus. ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 12 centros en total · contacto disponible | En reclutamiento | Fase 3 | 309objetivo | 12 / 1 | 2026 | 5 nov 2026 | |
| NCT06393374 | Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and di… ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 317 centros en total | En reclutamiento | Fase 3 | 1530objetivo | 317 / 31 | 2024 | 18 nov 2026 | |
| NCT05633654 | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine… ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 378 centros en total | En reclutamiento | Fase 3 | 1514objetivo | 378 / 12 | 2022 | 4 nov 2026 | |
| NCT04852887 | De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy. ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 832 centros en total · contacto disponible | En reclutamiento | Fase 3 | 1670objetivo | 832 / 4 | 2021 | 23 abr 2026 | |
| NCT06982521 | Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 (zovegalisib) + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment… ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 254 centros en total | En reclutamiento | Fase 3 | 540objetivo | 254 / 27 | 2025 | 5 nov 2026 | |
| NCT06605404 | Pan-tumor MRD Study The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, fo… ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 47 centros en total · contacto disponible | En reclutamiento | 1350objetivo | 47 / 1 | 2025 | 24 sept 2026 | ||
| NCT05862272 | A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with heavy menstrual bleeding associated with uterine leiomyoma… ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 120 centros en total | En reclutamiento | Fase 3 | 1000objetivo | 120 / 1 | 2023 | 6 ago 2025 | |
| NCT06581328 | A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months… ✓ Contacto✗ Reclamado Centro más cercano: Hutchinson, Kansas, United States — a 36 km · 101 centros en total · contacto disponible | En reclutamiento | Fase 4 | 200objetivo | 101 / 1 | 2025 | 18 nov 2026 | |
| NCT06571669 | BOOM-IBD2 Pivotal Clinical Trial Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tailb… ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 19 centros en total · contacto disponible | En reclutamiento | No aplicable | 137objetivo | 19 / 1 | 2025 | 6 ago 2026 | |
| NCT04553770 | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer This phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive breast cancer. Trastuzumab deruxtecan is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called derux… ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 9 centros en total · contacto disponible | En reclutamiento | Fase 2 | 88objetivo | 9 / 1 | 2020 | 10 nov 2025 | |
| NCT07629440 | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumoco… ✓ Contacto✗ Reclamado Centro más cercano: Derby, Kansas, United States — a 54 km · 134 centros en total | En reclutamiento | Fase 3 | 3230objetivo | 134 / 3 | 2026 | 18 nov 2026 | |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 279 centros en total · contacto disponible | En reclutamiento | 75.000objetivo | 279 / 6 | 2015 | 19 nov 2026 | ||
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early… ✓ Contacto✗ Reclamado Centro más cercano: Wichita, Kansas, United States — a 43 km · 751 centros en total · contacto disponible | En reclutamiento | 2900objetivo | 751 / 1 | 2022 | 4 nov 2026 |